Cargando…

Multiple drugs: COVID-19-pneumonia and increase in drug levels due to interactions: 2 case reports

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178050/ http://dx.doi.org/10.1007/s40278-021-96977-8

Ejemplares similares

Multiple drugs: Increased tacrolimus blood trough levels due to interaction and off-label use: case report
Publicado: (2020)

Multiple drugs: COVID-19 pneumonia: 4 case reports
Publicado: (2021)

Multiple drugs: COVID-19 and COVID-19 pneumonia: 4 case reports
Publicado: (2021)

Multiple drugs: COVID-19 and Streptococcus pneumoniae infection: case report
Publicado: (2022)

Multiple drugs: COVID-19 pneumonia and compassionate use of clazakizumab for COVID-19 pneumonia: case report
Publicado: (2020)

Multiple drugs: COVID-19, off label use and increased serum tacrolimus level following interaction: case report
Publicado: (2021)

Multiple drugs: Increased ciclosporin level following drug interaction and SARS-CoV-2 infection: case report
Publicado: (2020)

Multiple drugs: COVID-19 pneumonia and lack of efficacy: 3 case reports
Publicado: (2022)

Multiple drugs: Various toxicities, off-label use, and drug overdose due to drug interaction: case report
Publicado: (2020)

Clozapine toxicity due to a multiple drug interaction: a case report
por: Cadeddu, Giovanna, et al.
Publicado: (2015)

Multiple drugs: Drug-induced pneumonia, Legionella pneumophila pneumonia and lack of efficacy: case report
Publicado: (2021)

Multiple drugs: COVID-19-pneumonia, off-label use and lack of efficacy: 2 case reports
Publicado: (2021)

Multiple drugs: COVID-19 pneumonia, Pneumocystis jirovecii and Aspergillus fumigatus infection: case report
Publicado: (2020)

Multiple drugs: Lack of efficacy in COVID-19 pneumonia and off label use: case report
Publicado: (2021)

Multiple drugs: COVID-19 pneumonia, off-label use and lack of efficacy: case report
Publicado: (2021)

Multiple drugs: COVID-19 pneumonia secondary to hypogammaglobulinaemia and off-label use: case report
Publicado: (2022)

Multiple drugs: COVID-19: case report
Publicado: (2021)

Multiple drugs: Liver damage due to drug toxicity: 14 case reports
Publicado: (2021)

Multiple drugs: Carbapenem-resistant Klebsiella pneumoniae infection due to off-label use: 9 case reports
Publicado: (2021)

Multiple drugs: Pneumonitis and Pneumocystis jirovecii pneumonia: case report
Publicado: (2021)

Favipiravir/methotrexate interaction: Hepatotoxicity due to drug interaction: case report
Publicado: (2021)

Multiple drugs: Covid-19 reinfection: 2 case reports
Publicado: (2021)

Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activity
por: Bouatou, Yassine, et al.
Publicado: (2014)

Multiple drugs: Acute kidney injury due to drug interaction, Pneumocystis jiroveci Pneumocystosis and off-label use: case report
Publicado: (2021)

Apixaban/lopinavir/ritonavir interaction: An increase in drug level leading to high antifactory-Xa activity following drug-drug interaction: case report
Publicado: (2021)

Multiple drugs: COVID-19: 4 case reports
Publicado: (2021)

Multiple drugs: COVID-19 prolongation: case report
Publicado: (2021)

Unintentional sulfonylurea toxicity due to a drug–drug interaction: a case report
por: Gunaratne, Keith, et al.
Publicado: (2018)

Multiple drugs interaction: Reduction in drug level and QTc prolongation following off label use: 2 case reports
Publicado: (2020)

Multiple drugs interaction: Exacerbation of psoriasis and psoriatic arthritis following drug interaction: case report
Publicado: (2021)

Multiple drugs: COVID-19 infection: 4 case reports
Publicado: (2020)

Multiple drugs: Lymphopaenia and COVID-19 infection: case report
Publicado: (2020)

Multiple drugs: COVID-19 infection: 4 case reports
Publicado: (2021)

Multiple drugs: COVID-19 infection: 15 case reports
Publicado: (2021)

Multiple drugs: COVID-19 infection: 6 case reports
Publicado: (2021)

Multiple drugs: COVID‑19 infection: 6 case report
Publicado: (2022)

Multiple drugs: COVID-19 infection: 5 case reports
Publicado: (2022)

Multiple drugs: Pneumocystis jiroveci pneumonia, hospital acquired pneumonia and lack of efficacy: case report
Publicado: (2021)

Multiple drugs interaction: Off-label use and increased plasma concentration of rivaroxaban: case report
Publicado: (2021)

Multiple drugs: Pneumocystis jirovecii pneumonia and allergic rash: 3 case reports
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hg595ls1jfhkeknfp4q3k43vbk